Company / Current Assets
Minerva Neurosciences, Inc. Current Assets History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$22.3M
FY2024
5-year range
$22.3M / $62.2M
FY2020-FY2024
Trend
-47.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 8 years, ranging from $22M in FY2024 to $130M in FY2017.
Based on SEC 10-K filings.
$22M in FY2024 with a 5-year CAGR of -13.9%.
Declined from $40M to $22M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -29.0%
- 5-Year CAGR
- -13.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -13.9%, indicating a declining trend.
- In FY2024, current assets decreased 47.0% year-over-year.
- Peak current assets was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $22.3M | -47.0% |
| FY2023 | $42.0M | +4.6% |
| FY2022 | $40.2M | -35.4% |
| FY2021 | $62.2M | +126.7% |
| FY2020 | $27.4M | -41.8% |
| FY2019 | $47.1M | -47.6% |
| FY2018 | $90.0M | -30.5% |
| FY2017 | $129.5M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026